Providers

A nationwide study conducted in Denmark found an association between dementia incidence and previous exposure to infection, but the potential impacts of systemic inflammation or autoimmune diseases on dementia incidence were not as clear.

Millions are invested in researchers for the Cancer Moonshot initiative; some providers are charging patients for communicating online; health insurance coverage increased for half of states.

Panelists from the American College of Surgeons (ACS) and the American Urological Association spread awareness about the realities of prostate cancer, the importance of screening, and ways for men to approach their health concerns and prevention.

The authors use surgical resident assignment as an instrumental variable for discharge opioid prescribing and estimate the impact of discharge opioid supply on subsequent use.

The combination demonstrated durable survival benefits among patients with metastatic non–small cell lung cancer (mNSCLC) regardless of PD-L1 expression levels at a minimum follow-up of more than 6 years.

The combination therapy is the first FDA approved for the mobilization of hematopoietic stem cells prior to autologous transplantation in patients with multiple myeloma.

This article presents a descriptive review of a team-based care transformation model in a large primary care network, including core staffing, process improvement, and extended care teams.

This editorial describes several key lessons about the development of effective value-based care delivery.

New research suggests an association between gestational diabetes history and mortality over 30 years, regardless of whether it manifests into type 2 diabetes.

New research suggests conventional fractionated and hypofractionated proton postmastectomy radiotherapy (PMRT) yield similar tolerability and complication rates for patients following mastectomy.

A study found acute myeloid leukemia (AML) salvage therapy was independently associated with early mortality compared with frontline therapy, suggesting that algorithms measuring quality of care should incorporate risk mortality indices that factor in disease characteristics and treatment status.

Patients with SLE who reported being more satisfied in their lives were more likely to have higher physical and mental component summary scores.

In a longitudinal case study, researchers found that higher inflammation levels may predict poor outcomes following bariatric surgery.

A meta-analysis found that the use of magnetic resonance–guided daily adaptive stereotactic body radiotherapy (SBRT) correlated with fewer acute grade 2 or higher gastrointestinal (GI) or genitourinary (GU) toxicities compared with CT-guided non-adaptive SBRT in patients with prostate cancer.

A cross-sectional study suggests that mild cognitive impairment is associated with pulmonary arterial hypertension (PAH).

In part 1 of this 4 part series, Michael Thorpy, MD, talks about salt intake and how health guidelines and individual habits shape what kind of medication is right for patients with sleep disorders like excessive daytime sleepiness or narcolepsy.

The review summarized existing evidence around short- and long-term treatment-related toxicities among adolescents and young adults (AYAs), as well as gaps in care guidelines for AYA survivors of lymphoma.

Out of several factors, surgical complications were the only factor independently associated with emergency department (ED) readmission among patients who underwent surgery for ovarian carcinoma.

In an exploratory analysis, Hispanic men with primary and metastatic prostate cancer exhibited higher frequencies of certain altered genes compared to non-Hispanic men.

Severe and frequent ocular symptoms were more likely in adolescents and young adults who used e-cigarettes and cigarettes.

Biosimilars can improve access to treatment for patients who might not have been able to access biologics previously, explained Laura Wingate, executive vice president, Education, Support, & Advocacy, Crohn's & Colitis Foundation.

Adverse effects associated with glucocorticoid use among patients with rheumatoid arthritis may not be as burdensome as previously indicated.

Measuring biochemical recurrence (BCR) as a surrogate marker produces unreliable results as a primary end point for overall survival of patients with localized prostate cancer, a study found.

A recent study found that ultrasonography-based risk models for differentiation between benign and malignant ovarian tumors performed well in a diagnostic study conducted in a US cohort.

Researchers analyzed patient and clinician perspectives on neuropsychiatric (NP) symptom occurrence and found discrepancies potentially impacting patient care.